<DOC>
	<DOCNO>NCT01756417</DOCNO>
	<brief_summary>The purpose study investigate whether drug-drug interaction multiple dose canagliflozin ( JNJ-28431754 ) single dose metformin . The safety tolerability canagliflozin also assess .</brief_summary>
	<brief_title>A Study Investigate Whether Pharmacokinetic Pharmacodynamic Interactions Exist Between Metformin Canagliflozin ( JNJ-28431754 ) Healthy Volunteers</brief_title>
	<detailed_description>This study open-label ( volunteer study staff know identity assign treatment ) , fix sequence ( volunteer receive medication day ) , single multiple-dose study determine metformin ( blood glucose-lowering agent use treat patient diabetes ) affect pharmacokinetics ( ie , body affect drug ) pharmacodynamics ( ie , drug affect body ) canagliflozin ( drug currently investigate treatment type 2 diabetes mellitus ) . The effect canagliflozin pharmacokinetics pharmacodynamics metformin also evaluate . The study consist 3 phase : screening phase , open-label treatment phase , end-of-study ( follow-up ) phase . Each volunteer participate study approximately 39 day .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Canagliflozin</mesh_term>
	<criteria>Volunteers must Body Mass Index ( BMI [ weight ( kg ) / height ( ) 2 ] ) 18.5 35 kg/m2 , inclusive Volunteers must nonsmoker nontobacco user History currently active illness Investigator consider clinically significant exclude volunteer study could interfere interpretation study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Canagliflozin ( JNJ-28431754 )</keyword>
	<keyword>Metformin</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>